Bridgeway Capital Management, LLC Calyxt, Inc. Transaction History

Bridgeway Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.91 $24,689 - $93,612	-102,871 Reduced 70.08%	43,929 $11,000
Q1 2022 May 16, 2022	SELL	$1.02 - $2.46 $51,000 - $123,000	-50,000 Reduced 25.41%	146,800 $153,000
Q4 2021 Feb 14, 2022	BUY	$2.06 - $4.05 $58,710 - $115,425	28,500 Added 16.93%	196,800 $419,000
Q3 2021 Nov 15, 2021	BUY	$3.18 - $5.08 $95,400 - $152,400	30,000 Added 21.69%	168,300 $567,000
Q2 2021 Aug 16, 2021	SELL	$3.83 - $6.31 $134,050 - $220,850	-35,000 Reduced 20.2%	138,300 $556,000
Q1 2021 May 17, 2021	SELL	$4.25 - $12.01 $63,750 - $180,150	-15,000 Reduced 7.97%	173,300 $1.04 Million
Q4 2020 Feb 16, 2021	BUY	$3.21 - $5.68 $144,450 - $255,600	45,000 Added 31.4%	188,300 $795,000
Q1 2020 May 15, 2020	BUY	$2.48 - $7.85 $355,384 - $1.12 Million	143,300 New	143,300 $477,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.